Ibritumomab vs Vitamin K Antagonists (eg, warfarin)

Interacting Drugs
Ibritumomab
vs
Vitamin K Antagonists (eg, warfarin)
Security Level
Minor, Monitor Therapy
Mechanism
Vitamin K Antagonists (eg, warfarin): Antineoplastic Agents may enhance the anticoagulant effect of Vitamin K Antagonists. Antineoplastic Agents may diminish the anticoagulant effect of Vitamin K Antagonists.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Ibritumomab vs Vitamin K Antagonists (eg, warfarin)


Other Interactions of Ibritumomab

We are Developing Our database, More results coming soon.